Evidence map›Paper›PMID 40479577›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

GHSR-Foxo1 Signaling in Macrophages Promotes Liver Fibrosis via Inflammatory Response and Hepatic Stellate Cell Activation.

Da Mi Kim, Quan Pan, Zeyu Liu, Weiqi Ai, Hye Won Han, Sakhila K Banu, Robert Y L Tsai, Gus A Wright, Shaodong Guo, Yuxiang Sun

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Da Mi KimDepartment of Nutrition, Texas A&M University, College Station, TX, 77843, USA.
Quan PanDepartment of Nutrition, Texas A&M University, College Station, TX, 77843, USA.
Zeyu LiuDepartment of Nutrition, Texas A&M University, College Station, TX, 77843, USA.
Weiqi AiDepartment of Nutrition, Texas A&M University, College Station, TX, 77843, USA.
Hye Won HanDepartment of Nutrition, Texas A&M University, College Station, TX, 77843, USA.
Sakhila K BanuDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, 77843, USA.
Robert Y L TsaiInstitute of Biosciences and Technology, Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX, 77030, USA.
Gus A WrightDepartment of Veterinary Pathobiology, Texas A&M University, College Station, TX, 77843, USA.
Shaodong GuoDepartment of Nutrition, Texas A&M University, College Station, TX, 77843, USA.
Yuxiang SunDepartment of Nutrition, Texas A&M University, College Station, TX, 77843, USA.ORCID https://orcid.org/0000-0002-6656-3733

Funding

Nutrient-sensing GHS-R in macrophage reprogramming and inflamm-agingR01AG064869 · NIA · TEXAS A&M AGRILIFE RESEARCH · PI SUN, YUXIANG · 2019 to 2023
$2.1M
Hepatic TGFbeta1 in Control of Type 2 Diabetes and NASH via FoxO1 SignalingR01DK124588 · NIDDK · TEXAS A&M AGRILIFE RESEARCH · PI GUO, SHAODONG · 2022 to 2025
$2.0M
Targeting Insulin Resistance by Estrogen Receptor in Control of Type 2 Diabetes MellitusR01DK120968 · NIDDK · TEXAS A&M AGRILIFE RESEARCH · PI GUO, SHAODONG · 2019 to 2022
$1.4M
Transcriptional Regulation of Metabolic and Hepatic Homeostasis by FoxO SignalingR01DK095118 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI GUO, SHAODONG · 2012 to 2016
$1.4M
The role of GHS-R in macrophage reprogramming during meta-inflammationR01DK118334 · NIDDK · TEXAS A&M AGRILIFE RESEARCH · PI SUN, YUXIANG · 2019 to 2022
$1.2M
Cancer Prevention and Research Institute of Texas RP230063NIA NIH HHS R01 AG064869NIDDK NIH HHS R01 DK095118NIDDK NIH HHS R01 DK118334NIDDK NIH HHS R01 DK120968NIDDK NIH HHS R01 DK124588NIH HHS R01AG064869NIH HHS R01-DK095118NIH HHS R01DK118334NIH HHS R01-DK120968NIH HHS R01DK124588
6 · The paper itself

Abstract

Liver fibrosis is a severe liver disease directly linked to chronic inflammation, in which hepatic macrophages play a key role. Growth hormone secretagogue receptor (GHSR) is the receptor of nutrient-sensing hormone ghrelin that has essential functions in metabolism, inflammation, and wound-healing. However, the role of GHSR in liver fibrosis is unknown. This study uses a carbon tetrachloride (CCl

Indexed as

Forkhead Box Protein O1Hepatic Stellate CellsInflammationLiver CirrhosisMacrophagesReceptors, GhrelinAnimalsCarbon TetrachlorideDisease Models, AnimalMaleMiceMice, Inbred C57BLSignal TransductionCarbon TetrachlorideForkhead Box Protein O1Foxo1 protein, mouseReceptors, Ghrelinforkhead box protein o1 (Foxo1)growth hormone secretagogue receptors (GHSR)liver fibrosismacrophagestransforming growth factor (TGF)‐β1

Identifiers

PMID40479577
PMCPMC12412619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.